AC
AUPH icon

Antara Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Antara Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-609,500
Closed -$8.43M – 121
2020
Q4 		$8.43M Hold
609,500
– – 1.75% 11
2020
Q3 		$8.98M Buy
609,500
+289,200
+90% +$4.19M 1.25% 23
2020
Q2 		$5.21M Buy
320,300
+20,300
+7% +$325K 0.58% 25
2020
Q1 		$4.35M Buy
300,000
+150,000
+100% +$2.65M 0.71% 26
2019
Q4 		$3.04M Buy
+150,000
New +$1.38M 0.62% 33

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Antara Capital's AUPH Position: Q3 2023 in Review

Antara Capital sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2023, closing a stake of 500,000 shares — an estimated $4.89M sold.

Antara Capital first reported a position in AUPH in Q1 2020 and held it in 4 quarters. The position peaked at $4.84M in Q2 2023. 198 funds tracked by Wall St. Rank hold AUPH as of Q3 2023.

  • Antara Capital reported no remaining Aurinia Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Antara Capital sold 500,000 Aurinia Pharmaceuticals shares in Q3 2023, an estimated $4.89M.
  • Antara Capital first reported a position in Aurinia Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Antara Capital's Aurinia Pharmaceuticals position peaked at $4.84M in Q2 2023.
  • 198 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2023.

Based on Antara Capital's 13F filing for Q3 2023, filed 14 Nov 2023.